Kerala Vigilance and Anti-Corruption Bureau launched 'Operation Bhakshya Suraksha'. Surprise inspections targeted NFSA godowns and ration s...

Kashmir Medical College in Srinagar is undergoing significant development. The institution is being equipped with advanced technology and m...

Angel One has settled a securities law violation case with Sebi. The company paid ₹4.28 crore to resolve allegations of supervisory lapses....

Fertiliser supplies and prices will take months to return to normal. Natural gas and petroleum derivative supplies need to resume. Ammonia ...

Angel One has settled Sebi's adjudication and enquiry proceedings by paying Rs 4.28 crore. The regulator had alleged supervisory and monito...

The week of June 15-21, 2026, features a powerful astrological shift with a Gemini New Moon and Sun transit on June 15, fostering new begin...

The Central Information Commission has criticized the Petroleum and Natural Gas Regulatory Board. This is for not properly answering a Righ...

The Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...

Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...

Several states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...